E1	Procedure:T1 Name:T2
E7	Procedure:T7 Name:T8
E10	Condition:T10 Name:T11
E13	Condition:T13 Name:T14
E15	Procedure:T15 Name:T16 Temporality:E25
E19	Procedure:T19 Name:T20
E21	Procedure:T21 Name:T22 Temporality:E25
E24	Age:T30 Numeric-Filter:E39
E25	Eq-Comparison:T37 Operator:T26 Value:T124 Temporal-Unit:T125
E26	Eq-Comparison:T38 Value:T33 Operator:T73 Value2:T34
E27	Eq-Comparison:T39 Temporal-Period:T40
E28	Eq-Comparison:T41 Temporal-Period:T42 Temporal-Unit:T29 Value:T36
E2	Condition:T5 Name:T6 Stage:E5
E4	Modifier:T12 Modifies:T6
E5	Eq-Comparison:T25 Unit:T28 Value:T31 Value2:T35
E6	Procedure:T43 Name:T44
E8	Condition:T45 Name:T46
E9	Modifier:T47 Modifies:T46
E11	Eq-Comparison:T48 Temporal-Period:T49
E12	Procedure:T50 Name:T51 Temporality:E11
E20	Procedure:T55 Name:T56
E22	Modifier:T57 Modifies:T56
E29	Indication:T58 Indication-For:E20
E30	Procedure:T59 Name:T60
E31	Coreference:T61 Refers-To:E8
E32	Coreference:T62 Refers-To:E8
E36	Coreference:T66 Refers-To:E31
E37	Coreference:T67 Refers-To:E32
E39	Eq-Comparison:T69 Value:T32 Temporal-Unit:T27 Operator:T70
E40	Observation:T71 Name:T72 Numeric-Filter:E26
E41	Procedure:T74 Name:T75
E42	Modifier:T76 Modifies:T79
E43	Modifier:T77 Modifies:T79
E44	Condition:T78 Name:T79
E46	Observation:T81 Name:T82 Severity:T83
E47	Procedure:T84 Name:T85
E48	Negation:T86 Negates:E47
E49	Assertion:T87 Asserted:E47
E3	Observation:T3 Name:T4 Polarity:T89
E51	Condition:T90 Name:T91
E52	Modifier:T92 Modifies:T91
E53	Modifier:T93 Modifies:T91
E55	Study:T95 
E57	Condition:T97 Name:T98 Polarity:T99
E59	Study:T101 Study-Of:E60 Temporality:E28
E60	Drug:T102 
E61	Other:T103 Is-Other:E59
E62	Observation:T104 Name:T105 Polarity:T106
E23	Condition:T23 Name:T24
E63	Condition:T107 Name:T108
E64	Condition:T109 Name:T110
E65	Modifier:T111 Modifies:E63
E67	Condition:T113 Name:T114
E68	Modifier:T115 Modifies:T114
E17	Condition:T17 Name:T18
E69	Modifier:T116 Modifies:T18
E70	Condition:T117 Name:T118 Temporality:E27
E71	Procedure:T119 
E72	Assertion:T120 Asserted:E71
E73	Modifier:T121 Modifies:T14
E74	Study:T122 
E77	Condition:T127 
E78	Modifier:T129 Modifies:E77
E79	Procedure:T130 Name:T131
E81	Contraindication:T133 Contraindicates:E19 Contraindicates2:E79
E82	Procedure:T134 Name:T135
E83	Procedure:T136 Name:T137
E84	Negation:T138 Negates:E82
E85	Assertion:T139 Asserted:E84
T1	Procedure 185 211	adjuvant chemoradiotherapy
T2	Procedure-Name 185 211	adjuvant chemoradiotherapy
T7	Procedure 163 172	resection
T8	Procedure-Name 163 172	resection
T9	Life-Stage-And-Gender 1069 1075	female
T10	Condition 952 956	AIDS
T11	Condition-Name 952 956	AIDS
T13	Condition 1371 1386	febrile illness
T14	Condition-Name 1371 1386	febrile illness
T15	Procedure 1405 1417	chemotherapy
T16	Procedure-Name 1405 1417	chemotherapy
T19	Procedure 1499 1509	anesthesia
T20	Procedure-Name 1499 1509	anesthesia
T21	Procedure 1392 1401	Radiation
T22	Procedure-Name 1392 1401	Radiation
T26	Eq-Operator 1418 1424	within
T27	Eq-Temporal-Unit 376 381	years
T29	Eq-Temporal-Unit 1029 1034	weeks
T30	Age 385 388	age
T32	Eq-Value 373 375	18
T33	Eq-Value 432 434	70
T34	Eq-Value 435 438	100
T36	Eq-Value 1027 1028	4
T37	Eq-Comparison 1418 1432	within 4 weeks
T38	Eq-Comparison 432 438	70-100
T39	Eq-Comparison 1317 1323	Active
T40	Eq-Temporal-Period 1317 1323	Active
T41	Eq-Comparison 1021 1034	prior 4 weeks
T42	Eq-Temporal-Period 1021 1026	prior
T5	Condition 98 104	Glioma
T6	Condition-Name 98 104	Glioma
T12	Modifier 63 77	supratentorial
T25	Eq-Comparison 82 97	Grade III or IV
T28	Eq-Unit 82 87	Grade
T31	Eq-Value 88 91	III
T35	Eq-Value 95 97	IV
T43	Procedure 25 39	Histologically
T44	Procedure-Name 25 39	Histologically
T45	Condition 117 123	Glioma
T46	Condition-Name 117 123	Glioma
T47	Modifier 106 116	High Grade
T48	Eq-Comparison 134 143	undergone
T49	Eq-Temporal-Period 134 143	undergone
T50	Procedure 144 159	surgical biopsy
T51	Procedure-Name 144 159	surgical biopsy
T55	Procedure 304 310	biopsy
T56	Procedure-Name 304 310	biopsy
T57	Modifier 291 303	stereotactic
T58	Indication 314 323	indicated
T59	Procedure 269 276	imaging
T60	Procedure-Name 269 276	imaging
T61	Coreference 234 244	recurrence
T62	Coreference 248 259	progression
T66	Coreference 344 354	recurrence
T67	Coreference 355 366	progression
T69	Eq-Comparison 373 397	18 years of age or older
T70	Eq-Operator 389 397	or older
T71	Observation 403 431	Karnofsky Performance Status
T72	Observation-Name 403 431	Karnofsky Performance Status
T73	Eq-Operator 434 435	-
T74	Procedure 445 448	MRI
T75	Procedure-Name 445 448	MRI
T76	Modifier 468 505	stereotactically accessible enhancing
T77	Modifier 509 537	predominantly non- enhancing
T78	Condition 538 542	mass
T79	Condition-Name 538 542	mass
T81	Observation 609 620	mass effect
T82	Observation-Name 609 620	mass effect
T83	Severity 597 608	significant
T84	Procedure 565 574	resection
T85	Procedure-Name 565 574	resection
T86	Negation 553 556	not
T87	Assertion 557 564	require
T3	Observation 767 781	organ function
T4	Observation-Name 767 781	organ function
T89	Polarity 758 766	Adequate
T90	Condition 867 880	incapacitated
T91	Condition-Name 867 880	incapacitated
T92	Modifier 859 866	legally
T93	Modifier 847 855	mentally
T95	Study 900 905	study
T97	Condition 918 921	HIV
T98	Condition-Name 918 921	HIV
T99	Polarity 922 923	+
T101	Study 1008 1013	study
T102	Drug 1003 1007	drug
T103	Other 979 986	another
T104	Observation 1049 1063	pregnancy test
T105	Observation-Name 1049 1063	pregnancy test
T106	Polarity 1040 1048	Positive
T23	Condition 1165 1185	Diffuse subependymal
T24	Condition-Name 1165 1185	Diffuse subependymal
T107	Condition 1217 1224	disease
T108	Condition-Name 1217 1224	disease
T109	Condition 1212 1215	CSF
T110	Condition-Name 1212 1215	CSF
T111	Modifier 1189 1210	Cerebral Spinal Fluid
T113	Condition 1230 1236	Tumors
T114	Condition-Name 1230 1236	Tumors
T115	Modifier 1251 1261	cerebellum
T17	Condition 1267 1272	Tumor
T18	Condition-Name 1267 1272	Tumor
T116	Modifier 1273 1311	enhancement involving both hemispheres
T117	Condition 1324 1333	infection
T118	Condition-Name 1324 1333	infection
T119	Procedure 1344 1353	treatment
T120	Assertion 1334 1343	requiring
T121	Modifier 1359 1370	Unexplained
T122	Study 1436 1446	enrollment
T124	Eq-Value 1425 1426	4
T125	Eq-Temporal-Unit 1427 1432	weeks
T127	Condition 1461 1469	diseases
T129	Modifier 1452 1460	Systemic
T130	Procedure 1513 1522	operative
T131	Procedure-Name 1513 1522	operative
T133	Contraindication 1523 1527	risk
T134	Procedure 1554 1580	magnetic resonance imaging
T135	Procedure-Name 1554 1580	magnetic resonance imaging
T136	Procedure 1582 1585	MRI
T137	Procedure-Name 1582 1585	MRI
T138	Negation 1533 1542	Inability
T139	Assertion 1533 1542	Inability
A1	Life-Stage-And-Gender-Type T9 female
A2	Eq-Operator-Value T26 LTEQ
A3	Eq-Temporal-Unit-Value T27 year
A5	Eq-Temporal-Unit-Value T29 week
A7	Eq-Temporal-Period-Value T40 present
A8	Eq-Temporal-Period-Value T42 past
A4	Eq-Temporal-Period-Value T49 past
A9	Eq-Operator-Value T70 GTEQ
A10	Observation-Type-Value E40 clinical-score
A11	Eq-Operator-Value T73 BETWEEN
A12	Severity-Value T83 severe
A13	Assertion-Type-Value E49 hypothetical
A14	Polarity-Value T89 normal
A16	Polarity-Value T99 positive
A17	Polarity-Value T106 positive
A18	Assertion-Type-Value E72 hypothetical
A19	Eq-Temporal-Unit-Value T125 week
A21	Assertion-Type-Value E85 hypothetical
R1	Found-By Arg1:E2 Arg2:E6
R2	Equivalent-To Arg1:E8 Arg2:E2
R3	Found-By Arg1:E32 Arg2:E30
R4	Found-By Arg1:E44 Arg2:E41
R5	Treatment-For Arg1:E47 Arg2:E46
R6	If-Then Arg1:T9 Arg2:E62
R7	Abbrev-Of Arg1:E64 Arg2:E65
R8	Treatment-For Arg1:E71 Arg2:E70
R9	Caused-By Arg1:E81 Arg2:E77
R10	Abbrev-Of Arg1:E83 Arg2:E82
R11	And Arg1:E8 Arg2:E12
R12	Or Arg1:E12 Arg2:E7
R13	Before Arg1:E7 Arg2:E1
R14	Or Arg1:E31 Arg2:E32
R15	And Arg1:E1 Arg2:E31
R16	And Arg1:E30 Arg2:E20
R17	Or Arg1:E36 Arg2:E37
R18	Or Arg1:E42 Arg2:E43
R19	And Arg1:E44 Arg2:E48
R20	Or Arg1:E53 Arg2:E52
R21	During Arg1:E51 Arg2:E55
R22	Or Arg1:E57 Arg2:E10
R23	Or Arg1:E23 Arg2:E63
R24	Or Arg1:E21 Arg2:E15
R25	Before Arg1:E25 Arg2:E74
R26	Or Arg1:E19 Arg2:E79
